491 related articles for article (PubMed ID: 18958156)
1. In vitro identification and characterization of CD133(pos) cancer stem-like cells in anaplastic thyroid carcinoma cell lines.
Zito G; Richiusa P; Bommarito A; Carissimi E; Russo L; Coppola A; Zerilli M; Rodolico V; Criscimanna A; Amato M; Pizzolanti G; Galluzzo A; Giordano C
PLoS One; 2008; 3(10):e3544. PubMed ID: 18958156
[TBL] [Abstract][Full Text] [Related]
2. Cancer stem-like cell behavior in anaplastic thyroid cancer: A challenging dilemma.
Haghpanah V; Fallah P; Naderi M; Tavakoli R; Soleimani M; Larijani B
Life Sci; 2016 Feb; 146():34-9. PubMed ID: 26772823
[TBL] [Abstract][Full Text] [Related]
3. Targeting signal transducer and activator of transcription 3 pathway by cucurbitacin I diminishes self-renewing and radiochemoresistant abilities in thyroid cancer-derived CD133+ cells.
Tseng LM; Huang PI; Chen YR; Chen YC; Chou YC; Chen YW; Chang YL; Hsu HS; Lan YT; Chen KH; Chi CW; Chiou SH; Yang DM; Lee CH
J Pharmacol Exp Ther; 2012 May; 341(2):410-23. PubMed ID: 22328572
[TBL] [Abstract][Full Text] [Related]
4. Thyroid cancer stem-like cells and epithelial-mesenchymal transition in thyroid cancers.
Hardin H; Montemayor-Garcia C; Lloyd RV
Hum Pathol; 2013 Sep; 44(9):1707-13. PubMed ID: 23528862
[TBL] [Abstract][Full Text] [Related]
5. All-trans retinoic acid suppresses malignant characteristics of CD133-positive thyroid cancer stem cells and induces apoptosis.
Mei D; Lv B; Chen B; Xiao S; Jiang J; Xie Y; Jiang L
PLoS One; 2017; 12(8):e0182835. PubMed ID: 28817605
[TBL] [Abstract][Full Text] [Related]
6. CD133+ anaplastic thyroid cancer cells initiate tumors in immunodeficient mice and are regulated by thyrotropin.
Friedman S; Lu M; Schultz A; Thomas D; Lin RY
PLoS One; 2009; 4(4):e5395. PubMed ID: 19404394
[TBL] [Abstract][Full Text] [Related]
7. Analysis of multiple markers for cancer stem-like cells in human thyroid carcinoma cell lines.
Shimamura M; Nagayama Y; Matsuse M; Yamashita S; Mitsutake N
Endocr J; 2014; 61(5):481-90. PubMed ID: 24531915
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical detection of epithelialmesenchymal transition associated with stemness phenotype in anaplastic thyroid carcinoma.
Liu J; Brown RE
Int J Clin Exp Pathol; 2010 Oct; 3(8):755-62. PubMed ID: 21151388
[TBL] [Abstract][Full Text] [Related]
9. Latexin inhibits the proliferation of CD133+ miapaca-2 pancreatic cancer stem-like cells.
Xue ZX; Zheng JH; Zheng ZQ; Cai JL; Ye XH; Wang C; Sun WJ; Zhou X; Lu MD; Li PH; Cai ZZ
World J Surg Oncol; 2014 Dec; 12():404. PubMed ID: 25551472
[TBL] [Abstract][Full Text] [Related]
10. Targeting the BRAF Signaling Pathway in CD133pos Cancer Stem Cells of Anaplastic Thyroid Carcinoma.
Bozorg-Ghalati F; Hedayati M; Dianatpour M; Mosaffa N; Azizi F
Asian Pac J Cancer Prev; 2019 May; 20(5):1353-1360. PubMed ID: 31127889
[TBL] [Abstract][Full Text] [Related]
11. The sonic hedgehog signaling pathway maintains the cancer stem cell self-renewal of anaplastic thyroid cancer by inducing snail expression.
Heiden KB; Williamson AJ; Doscas ME; Ye J; Wang Y; Liu D; Xing M; Prinz RA; Xu X
J Clin Endocrinol Metab; 2014 Nov; 99(11):E2178-87. PubMed ID: 25078145
[TBL] [Abstract][Full Text] [Related]
12. [Sorting of CD133(+) subset cells in human gastric cancer and the identification of their tumor initiating cell-like properties].
Lu RQ; Wu JG; Zhou GC; Jiang HG; Yu JW; Jiang BJ
Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Feb; 15(2):174-9. PubMed ID: 22368028
[TBL] [Abstract][Full Text] [Related]
13. The stem cell marker CD133 associates with enhanced colony formation and cell motility in colorectal cancer.
Elsaba TM; Martinez-Pomares L; Robins AR; Crook S; Seth R; Jackson D; McCart A; Silver AR; Tomlinson IP; Ilyas M
PLoS One; 2010 May; 5(5):e10714. PubMed ID: 20502714
[TBL] [Abstract][Full Text] [Related]
14. Medullary thyroid carcinoma cell lines contain a self-renewing CD133+ population that is dependent on ret proto-oncogene activity.
Zhu W; Hai T; Ye L; Cote GJ
J Clin Endocrinol Metab; 2010 Jan; 95(1):439-44. PubMed ID: 19897677
[TBL] [Abstract][Full Text] [Related]
15. Cells with characteristics of cancer stem/progenitor cells express the CD133 antigen in human endometrial tumors.
Rutella S; Bonanno G; Procoli A; Mariotti A; Corallo M; Prisco MG; Eramo A; Napoletano C; Gallo D; Perillo A; Nuti M; Pierelli L; Testa U; Scambia G; Ferrandina G
Clin Cancer Res; 2009 Jul; 15(13):4299-311. PubMed ID: 19509143
[TBL] [Abstract][Full Text] [Related]
16. In vivo 5FU-exposed human medullary thyroid carcinoma cells contain a chemoresistant CD133+ tumor-initiating cell subset.
Kucerova L; Feketeova L; Kozovska Z; Poturnajova M; Matuskova M; Nencka R; Babal P
Thyroid; 2014 Mar; 24(3):520-32. PubMed ID: 24073856
[TBL] [Abstract][Full Text] [Related]
17. Chemoresistance of CD133+ cancer stem cells in laryngeal carcinoma.
Yang JP; Liu Y; Zhong W; Yu D; Wen LJ; Jin CS
Chin Med J (Engl); 2011 Apr; 124(7):1055-60. PubMed ID: 21542968
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of CD44 and CD133 as cancer stem cell markers for colorectal cancer.
Wang C; Xie J; Guo J; Manning HC; Gore JC; Guo N
Oncol Rep; 2012 Oct; 28(4):1301-8. PubMed ID: 22895640
[TBL] [Abstract][Full Text] [Related]
19. miR-130b Promotes CD133(+) liver tumor-initiating cell growth and self-renewal via tumor protein 53-induced nuclear protein 1.
Ma S; Tang KH; Chan YP; Lee TK; Kwan PS; Castilho A; Ng I; Man K; Wong N; To KF; Zheng BJ; Lai PB; Lo CM; Chan KW; Guan XY
Cell Stem Cell; 2010 Dec; 7(6):694-707. PubMed ID: 21112564
[TBL] [Abstract][Full Text] [Related]
20. [Experimental investigation of CD133 as a putative marker of tumor-initiating cell in laryngeal carcinoma].
Wei XD; Zhou L; Cheng L; Tian J
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2006 Dec; 41(12):940-4. PubMed ID: 17345710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
